NASDAQ:AXDX
Accelerate Diagnostics Stock News
$0.93
-0.0152 (-1.61%)
At Close: Apr 26, 2024
Need To Know: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Insiders Have Been Buying Shares
11:00am, Friday, 17'th Jul 2020
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
Accelerate Diagnostics Schedules Call to Review Second Quarter 2020 Results
12:00pm, Thursday, 16'th Jul 2020
Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, August 6, 2020 at 4:30 p.m. Eastern Time to review 2020 second quarter financial results.
Puma Biotechnology's licensing partner Specialised Therapeutics Asia received authorization to market NERLYNX in Malaysia.
AST Private Company Solutions Announces Partnership with Fund Administration Leader Standish Management
12:00am, Tuesday, 14'th Jul 2020
AST Private Company Solutions™ (AST PCS) today announced its latest strategic partnership with Standish Management, a leading fund administration prov
$2.47 Million in Sales Expected for Accelerate Diagnostics Inc (NASDAQ:AXDX) This Quarter
02:42am, Monday, 13'th Jul 2020
Wall Street analysts predict that Accelerate Diagnostics Inc (NASDAQ:AXDX) will announce sales of $2.47 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have p
Arsenal Supporters' Trust seek assurances from club over new loan deal
09:35am, Friday, 10'th Jul 2020
The Arsenal Supporters’ Trust have called on the club to provide more information after owners Kroenke Sports & Entertainment (KSE) provided a loan to pay bonds held by investment companies. Financ
How do I select an application security testing solution for my business? - Help Net Security
05:00am, Wednesday, 08'th Jul 2020
To select the perfect application security testing solution for your business, you need to think about an array of details.
Ast Groupe : Déclaration des transactions sur actions propres réalisées du 29 juin 2020 au 05 juillet 2020 | Zone bourse
04:05pm, Tuesday, 07'th Jul 2020Accelerate Diagnostics Inc (NASDAQ:AXDX) Given Consensus Rating of “Buy” by Analysts
03:26am, Tuesday, 07'th Jul 2020
Shares of Accelerate Diagnostics Inc (NASDAQ:AXDX) have received an average rating of “Buy” from the six ratings firms that are covering the stock, Marketbeat.com reports. One research analyst has
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), today announced it will join the Exelixis and Roche clinical collaboration and participate in the
Eaton Vance : Certain Eaton Vance Closed-End Funds Announce Telephonic Annual Meeting Of Shareholders On July 16, 2020 | MarketScreener
08:02pm, Wednesday, 01'st Jul 2020A property investment like no other available in Cheltenham
10:38am, Wednesday, 01'st Jul 2020
Your chance to own this incredible 11-bedroom regency-style building
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that addre
The
